Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. MorphoSys AG
  6. News
  7. Summary
    MOR   DE0006632003

MORPHOSYS AG

(MOR)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 09/20 08:44:29 am
40.625 EUR   -2.60%
09/17European ADRs Down Nearly 2% Friday as Mining, Steel Shares Drop
MT
09/17MORPHOSYS : Morgan Stanley keeps its Buy rating
MD
09/15European ADRs Modestly Higher Wednesday as Energy Stocks Rally
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

MorphoSys AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

07/30/2021 | 08:41am EDT
MorphoSys AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

2021-07-30T12:30:02Z

MorphoSys AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Publication of total number of voting rights

1. Details of issuer

MorphoSys AG
Semmelweisstr. 7
82152 Planegg
Germany

2. Type of capital measure

Type of capital measure Date of status / date of effect
X Conditional capital increase (Sec. 41 para. 2 WpHG) 30.07.2021
X Other capital measure (Sec. 41 para. 1 WpHG) 30 Jul 2021

3. New total number of voting rights:

34231943
Gemäß §41

Disclaimer

MorphoSys AG published this content on 30 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 July 2021 12:38:15 UTC.


ę Publicnow 2021
All news about MORPHOSYS AG
09/17European ADRs Down Nearly 2% Friday as Mining, Steel Shares Drop
MT
09/17MORPHOSYS : Morgan Stanley keeps its Buy rating
MD
09/15European ADRs Modestly Higher Wednesday as Energy Stocks Rally
MT
09/13MORPHOSYS : Goldman Sachs withdraws its Sell rating
MD
09/10European ADRs Move Higher in Friday Trading
MT
09/08European ADRs Move Lower in Wednesday Trading
MT
09/07European ADRs Move Lower in Tuesday Trading
MT
09/02MORPHOSYS : Barclays reiterates its Neutral rating
MD
09/01European ADRs Move Higher in Wednesday Trading
MT
08/31MORPHOSYS AG : Release according to Article 40, Section 1 of the WpHG [the Germa..
PU
More news
Analyst Recommendations on MORPHOSYS AG
More recommendations
Financials
Sales 2021 171 M 200 M 200 M
Net income 2021 -194 M -228 M -228 M
Net cash 2021 715 M 837 M 837 M
P/E ratio 2021 -9,52x
Yield 2021 -
Capitalization 1 423 M 1 671 M 1 666 M
EV / Sales 2021 4,15x
EV / Sales 2022 3,19x
Nbr of Employees 607
Free-Float 99,7%
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 41,71 €
Average target price 90,54 €
Spread / Average Target 117%
EPS Revisions
Managers and Directors
Jean-Paul Kress CEO & Chairman-Management Board
Sung H. Lee Chief Financial Officer
Marc Cluzel Chairman-Supervisory Board
Malte Peters Chief Research & Development Officer
Roland Wandeler Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
MORPHOSYS AG-55.54%1 671
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420